PPT-Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial

Author : keanu817 | Published Date : 2024-10-30

RADAR Trial Raltegravir Darunavirr versus TDFFTC Darunavirr RADAR Study Design Source Bedimo RJ et al PLoS One 20149e106221 Darunavir QD Ritonavir QD Raltegravir

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Raltegravir + Darunavir/r versus TDF-FTC..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial: Transcript

RADAR Trial Raltegravir Darunavirr versus TDFFTC Darunavirr RADAR Study Design Source Bedimo RJ et al PLoS One 20149e106221 Darunavir QD Ritonavir QD Raltegravir BID . Evidence-Based Approaches. Simply Speaking. ®. HIV “Essentials for Optimal Care of HIV Patients: Evidence-Based Approaches” is. Copyrighted 2018 by Practice Point Communications, unless otherwise noted. All rights reserved.. By. Bani Tamraz, . Pharm.D. ., Ph.D.. Associate Clinical Professor. School of Pharmacy. Research Interests. Identification of . genetic . determinants of drug response. Translate to new diagnostics and treatment strategies . Selected Adverse Eventstransporters of creatinine This increases serum creatinine and reduces estimated glomerular filtration rate with no change in glomerular functionSpecial Instructionsis not inter Joseph J. Eron, Jr, MD. Professor of Medicine. University of North Carolina. Chapel Hill, North Carolina. Panelists. Constance Benson. Hyman Scott. Annie . Luetkemeyer. Robert . Schooley. Financial Relationships With Commercial Entities. PROTEA Trial. Darunavir/r . M. onotherapy. versus Triple Therapy . PROTEA. : Study Design. Source: . Antinori. A, et al. . J Int AIDS Soc. 2014;17:19525.. Darunavir 800 mg QD. + Ritonavir 100 mg . QD. DUAL-GESIDA. Dual Maintenance ART with RTV-Boosted Darunavir + . Lamivudine. DUAL . GESIDA: . Study Design. Source: . Pulido. . F, . et al. . Clin Infect . Dis.. . 2017;65:2112-8.. DRV + RTV + 3TC. Lopinavir. -RTV in Treatment Experienced. TITAN Trial. Darunavir/. r . versus Lopinavir/r in Treatment-Experienced . TITAN. : Study Design. Source: . Madruga. JV, et al. Lancet. 2007;370:49-58. . Darunavir. FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs . FLAMINGO: Study Design. Source: . Clotet. B, et al. . Lancet. 2014;383:2222-31. . Dolutegravir + . TDF-FTC or ABC-3TC. (n = 242). Darunavir + Ritonavir + . SPRING-2 Study. Dolutegravir. versus Raltegravir. SPRING-2: Design. Source: . Raffi. F, et al. Lancet. 2013;381:735-43.. Dolutegravir. : 50 mg QD. Fixed-dose NRTI backbone*. (n = 411). Raltegravir. POTENT Trial. Tipranavir. /. r . versus Darunavir. /r . in Treatment-Experienced . POTENT. : Study Design. Source: . Elgadi. MM, et al. . Drugs R D. . 2011;11:. 295-. 302.. Tipranavir. . + . R. itonavir BID . Diese Präsentation dient ausschließlich der wissenschaftlichen Information gegenüber ärztlichen Fachkreisen. . Die Präsentation enthält keine werblichen Aussagen und dient nicht zu Werbezwecken. . DRIVE FORWARD. Doravirine. + 2 NRTIs vs. Darunavir + Ritonavir + 2 NRTIs. DRIVE FORWARD: Design. Source: Molina J-M, et al. Lancet HIV. 2018;5:e211-20.. Doravirine. + 2 NRTIs. (n = 385). Darunavir + RTV + 2 NRTIs. POWER 1 and 2. Darunavir. /. r versus other PIs in Treatment-Experienced . POWER 1 and 2. : Study Design. Source: . Clotet. B, et al. . Lancet. . 2007;369:. 1169-78.. Darunavir BID + RTV BID + OBR . NEAT001/ANRS 143 Trial. Darunavir/r + Raltegravir versus Darunavir/r + TDF-FTC. NEAT001/ANRS143: Study Design. Source: . Raffi. F, et al. Lancet. 2014;384:1942-51. .. Darunavir + Ritonavir QD. + Raltegravir BID .

Download Document

Here is the link to download the presentation.
"Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.